Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

NCT06678724 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancers- Squamous Cell
Head and Neck Cancer Metastatic
Recurrent Head and Neck Squamous Cell Carcinoma

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]